Obayashi to Acquire Multiplex in $526M Expansion Deal 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Trump Says Anthropic No Longer Seen as National Security Threat 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
BHP Shares Fall as Jansen Potash Project Costs Surge 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
Walgreens Boots Alliance Inc. (NASDAQ: WBA) is reportedly close to a $10 billion buyout deal with private equity firm Sycamore Partners, according to The Wall Street Journal. The deal, which could be finalized by Thursday, would take the struggling pharmacy chain private.
Sycamore is expected to offer between $11.30 and $11.40 per share in cash, with potential performance-based incentives. If the acquisition proceeds, Sycamore is likely to retain Walgreens' core U.S. retail operations while divesting or taking public other parts of the company.
Once a dominant force in U.S. pharmacy retail, Walgreens has seen its market value plummet from over $100 billion in 2015 to below $8 billion by late 2024. The company has struggled with declining prescription margins and an unsuccessful push into primary care. Under CEO Tim Wentworth, Walgreens has been closing underperforming stores in an effort to stabilize operations.
Sycamore, known for retail investments like its 2017 acquisition of Staples, aims to reposition Walgreens for long-term growth.
